MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY:XLV)

146.61 -0.71 (-0.48%)
Streaming Delayed Price Updated: 12:42 PM EDT, May 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
42 43 Next >
News headline image
Healthcare And Life Science Funds And ETFs Performance 2023-2024 ↗
Healthcare stocks usually provide a defensive posture to a stock portfolio. 
Via Talk Markets
Topics ETFs
News headline image
Markets suddenly price Eli Lilly stock for a breakout on earnings
The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up 
Via MarketBeat
Topics Bonds Economy
News headline image
US Stocks Rise At Week's Start, Tesla Rebounds, SoFi, Lucid Shine: What's Driving Markets Monday? ↗
Wall Street witnessed slight gains at midday on Monday, with investors eagerly awaiting a series of critical earnings reports, the Federal Reserve’s meeting on Wednesday and the much-anticipated job... 
Via Benzinga
News headline image
XLV Making Strong Reaction Higher From Extreme Area ↗
In this article, we will look at the past performance of the 4-hour Elliott Wave Charts of XLV 
Via Talk Markets
News headline image
Pfizer’s earnings growth trade at a deep discount, suddenly a buy
The healthcare sector is set to attract a new inflow of investment dollars, as seen in business activity and employment. Pfizer is the clear sector favorite 
Via MarketBeat
Topics Economy
News headline image
Just What Powers The SPY ↗
The S&P 500 closed the week below fresh highs thanks to a bout in tech and relative weakness in some semiconductors. The rally is broadening, though, with XLI and XLV appearing to be well-positioned. 
Via Talk Markets
Topics Stocks
News headline image
Stocks Ease Despite Benign Inflation Data, Bitcoin Stages Comeback: What's Driving Markets Friday? ↗
Stocks mixed in New York, with investors assessing mild inflation report and strong personal spending figures. Short-term Treasury yields rise, tech stocks lag, and Bitcoin surges 4.9%. Intel stock... 
Via Benzinga
Topics Economy
News headline image
5 top healthcare stocks for earnings growth in 2024
2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed. 
Via MarketBeat
News headline image
Baby Bust: Will Falling Global Birth Rates Drive Markets Lower? ↗
In the U.S., the birth rate is still growing, but at a much slower rate since the global financial crisis in 2008. 
Via Benzinga
News headline image
Weekly Market Pulse: Is The Recession Finally Here? ↗
You need to sell when things look great – but not too soon – and buy when things look awful – but not too soon. 
Via Talk Markets
Topics Economy
News headline image
Pfizer, Autodesk, AbbVie And More: CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named Health Care Select Sector SPDR Fund (NYSE: XLV) 
Via Benzinga
News headline image
Did Today's Volume Signal New Record Highs Ahead Of Sentiment ↗
An analysis of the major indexes' movement on higher than average volume. 
Via Talk Markets
News headline image
AI Drives Tech Rebound, Oil Soars, Bitcoin Tumbles: What's Driving Markets Thursday? ↗
During midday Thursday trading in New York, U.S. stocks displayed mixed performance, with the technology sector outperforming others as investors maintained a bullish outlook on artificial... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Healthcare Sector Is Off To A Strong, Market-Leading Start In 2024 ↗
After a modest loss in 2023, shares in the healthcare sector are enjoying a market-leading rebound so far in the new year. 
Via Talk Markets
News headline image
US Stocks Sink, Tech And Real Estate Hit Hard Amid Rate Concerns, Dollar Surge: What's Driving Markets Wednesday? ↗
Another day of losses shook up Wednesday’s stock trading session on Wall Street. All major U.S. stock indices in the red, as investors expressed concerns that the Federal Reserve is not in a rush to... 
Via Benzinga
Topics Economy
News headline image
Are CVS store closures prescription for better financial health?
CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry. 
Via MarketBeat
Topics Economy
News headline image
UnitedHealth's rising premiums could cushion stubborn inflation
The healthcare sector is one of the prime suspects to attract safety-seeking investors in the coming market shift. Within it, THIS stock can prove a winner 
Via MarketBeat
Topics Economy
News headline image
2023 Year-End Sector Review – Part 2 ↗
In this 2023 year-end sector review, we will take a look at what kind of year it was for healthcare, industrial, technology, materials, REITs, and utility sectors. Additionally, how is 2024 shaping up... 
Via Talk Markets
News headline image
AstraZeneca: Rebound in 2024 with double-digit earnings growth
AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition 
Via MarketBeat
News headline image
S&P 500's Projected EPS Growth In 2024: Why QQQ, QQQM Might Lead The Way ↗
The S&P 500 is poised to deliver double-digit growth to investors in 2024, fueled by 3 sectors. Even then, the Nasdaq-100 could outpace S&P 500. Here's why. 
Via Benzinga
Topics Stocks
News headline image
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
Via MarketBeat
Topics ETFs
News headline image
Are defensive sectors ready to outshine growth in 2024?
Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead. 
Via MarketBeat
News headline image
Charted: S&P 500 Sector Performance In 2023 ↗
Information Technology, Communication Services, and Consumer Discretionary were the three biggest winners in 2023, all of them up more than 40% for the year. 
Via Talk Markets
Topics Stocks
News headline image
US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday? ↗
The early 2024 sell-off is intensifying on Wall Street, with all major stock averages in the red on the second trading day of 2024. 
Via Benzinga
News headline image
Did Santa Claus Claus Leave Town A Day Early? ↗
With the exception of the Dow, stocks are down hard to begin the new calendar year. 
Via Talk Markets
Topics Stocks
News headline image
3 Biotech Stocks Set for Breakthroughs in 2024 ↗
With groundbreaking advancements in new medicine and science, 2024 holds a promising future for these biotech stocks. 
Via InvestorPlace
News headline image
Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday? ↗
Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York. 
Via Benzinga
News headline image
2023 Russell 1,000 Average Stock Performance By Sector ↗
2023 turned out to be a fantastic year for stocks after a horrible 2022. 
Via Talk Markets
News headline image
The Short-Term Uptrend May Be On Its Last Legs ↗
Believe it or not, the short-term uptrend looks set to continue, but it does appear to be on its last legs. It's time to prepare for a pullback in prices by having cash to deploy back into stocks when... 
Via Talk Markets
News headline image
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.  
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story